Research Article

Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics

Table 4

Relationship between risk level and clinical parameters; represents significant value.

SubgroupHigh riskLow riskTotal

Age0.447
 <60114 (22.85%)106 (21.24%)220
 ≥60135 (27.05%)144 (28.86%)279
Gender0.001
 Male199 (39.88%)167 (33.47%)366
 Female50 (10.02%)83 (16.63%)133
Stage0.073
 I+II47 (9.42%)58 (11.62%)105
 III+IV202 (40.48%)192 (38.48%)394
T stage0.454
 Tis, T1, T287 (17.83%)89 (18.24%)176
 T361 (12.50%)71 (14.55%)132
 T496 (19.67%)84 (17.21%)180
N stage0.784
 N0122 (25.42%)118 (24.58%)240
 N1+N2119 (24.79%)121 (25.21%)240
M stage0.677
 M0234 (48.85%)240 (50.10%)474
 M12 (0.42%)3 (0.63%)5
Neoplasm status0.029
 Tumor free146 (32.37%)168 (37.25%)314
 With tumor79 (17.52%)58 (12.86%)137
Vital status0.032
 Alive130 (26.05%)152 (30.46%)282
 Dead119 (23.85%)98 (19.64%)217